Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 6 of 6 clinical reviews.
A clinician-reviewed guide to delayed-onset and rare adverse events from vardenafil (Levitra/Staxyn), including NAION, hearing loss, prolonged erection, and cardiovascular effects, with trial data and FDA label citations.
Read clinical reviewA comprehensive clinical review of rare but serious adverse events associated with vardenafil (Levitra/Staxyn), including NAION, priapism, QTc prolongation, sudden hearing loss, and hypotension, with primary-source citations and prescriber guidance.
Read clinical reviewA clinician-reviewed guide to vardenafil adverse events, discontinuation effects, rare side effects, and what the FDA label and post-market data say about stopping the drug safely.
Read clinical reviewA detailed breakdown of vardenafil adverse event rates from Phase III trials, FDA labeling, FAERS reports, and post-market literature, with dose-by-dose incidence data.
Read clinical reviewA physician-reviewed guide to vardenafil (Levitra/Staxyn) side effects, including rare but potentially permanent adverse events such as NAION, priapism, and sudden hearing loss, with citations from clinical trials, FDA labeling, and post-market surveillance.
Read clinical reviewA clinician-reviewed breakdown of vardenafil adverse events by severity grade and patient phenotype, drawing on Phase III trial data, FDA labeling, and FAERS post-market reports.
Read clinical review